This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN rallied 3.05% to $2.70 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.56% to 4,155.17 and the Dow Jones Industrial Average DJIA rising 1.29% to 32,812.50. This was the stock's second consecutive day of gains. Ocugen Inc. closed $14.95 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. ADVM rose 6.11% to $1.39, Ocular Therapeutix Inc. OCUL rose 6.11% to $4.69, and Kodiak Sciences Inc. KOD rose 3.73% to $8.62. Trading volume (4.6 M) remained 1.6 million below its 50-day average volume of 6.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 3, 2022.
(END) Dow Jones Newswires
August 03, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.